Works matching AU Padilla, Byron

Results: 9

Reconstrucción Post-Amputación: Perspectivas Actuales en Cirugía para Mejorar la Movilidad y la Integración del Paciente.

Published in:

Tesla Revista Científica, 2023, v. 3, n. 2, p. 1, doi. 10.55204/trc.v3i2.e267

By:

Macías Rodríguez, José Isaac;
Santos león, Karla Modesta;
Padilla Duchi, Byron Héctor;
Robles Barahona, Nahin Isaac;
Herrera Lozada, Alexandra Elizabeth;
Rea Chela, Victoria Johanna;
Limones Espín, Diana Mercedes

Publication type:

Article

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.

Published in:

Rheumatology & Therapy, 2024, v. 11, n. 3, p. 633, doi. 10.1007/s40744-024-00657-2

By:

Östör, Andrew;
Van den Bosch, Filip;
Papp, Kim;
Asnal, Cecilia;
Blanco, Ricardo;
Aelion, Jacob;
Carter, Kyle;
Stakias, Vassilis;
Lippe, Ralph;
Drogaris, Leonidas;
Soliman, Ahmed M.;
Chen, Michael M.;
Padilla, Byron;
Kivitz, Alan

Publication type:

Article

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial.

Published in:

Rheumatology & Therapy, 2024, v. 11, n. 3, p. 617, doi. 10.1007/s40744-024-00654-5

By:

Kristensen, Lars Erik;
Keiserman, Mauro;
Papp, Kim;
McCasland, Leslie;
White, Douglas;
Carter, Kyle;
Lippe, Ralph;
Photowala, Huzefa;
Drogaris, Leonidas;
Soliman, Ahmed M.;
Chen, Michael;
Padilla, Byron;
Behrens, Frank

Publication type:

Article

Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials.

Published in:

Journal of Dermatological Treatment, 2024, v. 35, n. 1, p. 1, doi. 10.1080/09546634.2024.2342383

By:

Merola, Joseph F.;
Armstrong, April;
Khattri, Saakshi;
Paek, So Yeon;
Padilla, Byron;
Yue, Cuiyong;
Photowala, Huzefa;
Kaplan, Blair;
Kristensen, Lars Erik

Publication type:

Article

Six‐Month Use of Droxidopa for Neurogenic Orthostatic Hypotension.

Published in:

Movement Disorders Clinical Practice, 2019, v. 6, n. 3, p. 235, doi. 10.1002/mdc3.12726

By:

François, Clément;
Shibao, Cyndya A.;
Biaggioni, Italo;
Duhig, Amy M.;
McLeod, Kim;
Ogbonnaya, Augustina;
Quillen, Apryl;
Cannon, Joan;
Padilla, Byron;
Yue, Binglin;
Orloski, Laurie;
Kymes, Steven M.

Publication type:

Article

Enthesitis and Dactylitis Resolution with Risankizumab for Active Psoriatic Arthritis: Integrated Analysis of the Randomized KEEPsAKE 1 and 2 Trials.

Published in:

Dermatology & Therapy, 2024, v. 14, n. 6, p. 1517, doi. 10.1007/s13555-024-01174-4

By:

Kwatra, Shawn G.;
Khattri, Saakshi;
Amin, Ahmad Z.;
Ranza, Roberto;
Kaplan, Blair;
Shi, Linyu;
Padilla, Byron;
Soliman, Ahmed M.;
McGonagle, Dennis

Publication type:

Article

Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 2, p. 407, doi. 10.1007/s13555-021-00660-3

By:

Lebwohl, Mark G.;
Soliman, Ahmed M.;
Yang, Hongbo;
Wang, Jessie;
Hagan, Kaitlin;
Padilla, Byron;
Pinter, Andreas

Publication type:

Article

Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial.

Published in:

Dermatology & Therapy, 2021, v. 11, n. 2, p. 487, doi. 10.1007/s13555-021-00490-3

By:

Papp, Kim A.;
de Vente, Saskia;
Zeng, Jiewei;
Flack, Mary;
Padilla, Byron;
Tyring, Stephen K.

Publication type:

Article

Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study.

Published in:

Rheumatology, 2023, v. 62, n. 6, p. 2122, doi. 10.1093/rheumatology/keac605

By:

Östör, Andrew;
Bosch, Filip Van den;
Papp, Kim;
Asnal, Cecilia;
Blanco, Ricardo;
Aelion, Jacob;
Lu, Wenjing;
Wang, Zailong;
Soliman, Ahmed M;
Eldred, Ann;
Padilla, Byron;
Kivitz, Alan

Publication type:

Article